In vitro evaluation of betamethasone-loaded nanoparticles

Drug Development and Industrial Pharmacy

Volumn 31, Issue 1, 2005, Pages 19-24

  Arica, Betül ^a   Lamprecht, Alf ^b  

^a HACETTEPE UNIVERSITY   (Turkey)

^b UNIVERSITÉ DE LORRAINE   (France)

Author keywords

Betamethasone; Inflammatory diseases; Nanoparticles; Poly caprolactone ; Polyvinyl alcohol; Sodium cholate

Indexed keywords

BETAMETHASONE; CHOLIC ACID; DRUG CARRIER; NANOPARTICLE; POLYCAPROLACTONE; POLYVINYL ALCOHOL; SURFACTANT;

AQUEOUS SOLUTION; ARTICLE; BIOCOMPATIBILITY; COLLOID; DRUG STABILITY; INFLAMMATION; PARTICLE SIZE; PRECIPITATION; SCANNING ELECTRON MICROSCOPY; SUSTAINED DRUG RELEASE; VISCOSITY; ZETA POTENTIAL;

BETAMETHASONE; DRUG COMPOUNDING; ELECTROCHEMISTRY; EMULSIONS; GLUCOCORTICOIDS; KINETICS; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; PARTICLE SIZE; SURFACE-ACTIVE AGENTS;

EID: 12844258882     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.1081/DDC-43937     Document Type: Article

References (12)

1. Coffin, M. D., & McGinity, J. W. (1992). Biodegradable pseudolatexes: the chemical stability of poly(D,L-lactide and poly(ε-caprolactone) nanoparticles in aqueous media. Pharmaceutical Research, 9(2), 200-205.
2. Horisawa, E., Hirota, T., Kawazoe, S., Yamada, J., Yamamoto, H., Takeuchi, H., & Kawashima, Y. (2002). Prolonged anti-inflammatory action of DL-lactide/glycolide copolymer nanospheres containing betamethasone sodium phosphate for an intraarticular delivery system in antigen-induced arthritic rabbit. Pharmaceutical Research, 19(4), 403-410.
3. Landry, F. B., Bazile, D. V., Spenlehauer, G., Veillard, M., & Kreuter, J. (1998). Peroral administration of 14C-poly(dl-lactic acid) nanoparticles coated with human serum albumin or polyvinyl alcohol to guinea pigs. Journal of Drug Targeting, 6(4), 293-307.
4. Lamprecht, A., Schäfer, U., & Lehr, C. M. (2001). Size dependent targeting of micro- and nanoparticulate carriers to the inflamed colonic mucosa. Pharmaceutical Research, 18(6), 788-793.
5. Lamprecht, A., Ubrich, N., Yamamoto, H., Schäfer, U., Takeuchi, H., Lehr, C. M., Maincent, P., & Kawashima, Y. (2001). Design of rolipram loaded nanoparticles: comparison of two preparation methods. Journal of Controlled Release, 71(3), 297-306.
6. Lamprecht, A., Ubrich, N., Yamamoto, H., Schäfer, U., Takeuchi, H., Maincent, P., Kawashima, Y., & Lehr, C. M. (2001). Biodegradable nanoparticles for the targeted drug delivery in the treatment of inflammatory bowel disease. Journal of Pharmacology and Experimental Therapeutics, 299(2), 775-781.
7. Petersen, M. C., Nation, R. L., McBride, W. G., Ashley, J. J., & Moore, R. G. (1983). Pharmacokinetics of betamethasone in healthy adults after intravenous administration. European Journal of Clinical Pharmacology, 25(5), 643-650.
8. Pitt, C. G., Hendren, R. W., Schindler, A., & Woodward, S. C. (1984). The enzymatic surface erosion of aliphatic polyesters. Journal of Controlled Release, 1(1), 3-14.
9. Quellec, P., Gref, R., Perrin, L., Dellacherie, E., Sommer, F., Verbavatz, J. M., & Alonso, M. J. (1998). Protein encapsulation within polyethylene glycol-coated nanospheres. I. Physicochemical characterization. Journal of Biomedical Materials Research, 42(1), 45-54.
10. Ravivarapu, H. B., Lee, H., & DeLuca, P. P. (2000). Enhancing initial release of peptide from poly(d,l-lactide-co-glycolide) (PLGA) microspheres by addition of a porosigen and increasing drug load. Pharmaceutical Development and Technology, 5(2), 287-296.
11. Sampath, S. S., Garvin, K., & Robinson, D. H. (1992). Preparation and characterization of biodegradable poly(D,L-lactic acid) gentamicin delivery systems. International Journal of Pharmaceutics, 78(1-3), 165-174.
12. Sivaramakrishnan, R., Nakamura, C., Mehnert, W., Korting, H. C., Kramer, K. D., & Schäfer-Korting, M. (2004). Glucocorticoid entrapment into lipid carriers-characterisation by parelectric spectroscopy and influence on dermal uptake. Journal of Controlled Release, 97(3), 493-502.